• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重背景下心血管疾病危险因素对主要心血管事件预防和管理的影响

Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

作者信息

Crisan Liliana, Wong Nathan, Sin Don D, Lee Hwa Mu

机构信息

Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, Irvine, CA, United States.

Division of Respiratory Medicine, Department of Medicine, University of British Columbia and Centre for Heart Lung Innovation, Vancouver, BC, Canada.

出版信息

Front Cardiovasc Med. 2019 Jun 25;6:79. doi: 10.3389/fcvm.2019.00079. eCollection 2019.

DOI:10.3389/fcvm.2019.00079
PMID:31294030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6603127/
Abstract

There is compelling epidemiological evidence that airway exposure to cigarette smoke, air pollution particles, as well as bacterial and viral pathogens is strongly related to acute ischemic events. Over the years, there have been important animal and human studies that have provided experimental evidence to support a causal link. Studies show that patients with cardiovascular diseases (CVDs) or risk factors for CVD are more likely to have major adverse cardiovascular events (MACEs) after an acute exacerbation of chronic obstructive pulmonary disease (COPD), and patients with more severe COPD have higher cardiovascular mortality and morbidity than those with less severe COPD. The risk of MACEs in acute exacerbation of COPD is determined by the complex interactions between genetics, behavioral, metabolic, infectious, and environmental risk factors. To date, there are no guidelines regarding the prevention, screening, and management of the modifiable risk factors for MACEs in the context of COPD or COPD exacerbations, and there is insufficient CVD risk control in those with COPD. A deeper insight of the modifiable risk factors shared by CVD, COPD, and acute exacerbations of COPD may improve the strategies for reduction of MACEs in patients with COPD through vaccination, tight control of traditional CV risk factors and modifying lifestyle. This review summarizes the most recent studies regarding the pathophysiology and epidemiology of modifiable risk factors shared by CVD, COPD, and COPD exacerbations that could influence overall morbidity and mortality due to MACEs in patients with acute exacerbations of COPD.

摘要

有令人信服的流行病学证据表明,气道暴露于香烟烟雾、空气污染颗粒以及细菌和病毒病原体与急性缺血性事件密切相关。多年来,重要的动物和人体研究提供了实验证据来支持因果关系。研究表明,患有心血管疾病(CVD)或有CVD风险因素的患者在慢性阻塞性肺疾病(COPD)急性加重后更有可能发生主要不良心血管事件(MACE),且COPD病情越严重的患者,其心血管死亡率和发病率高于病情较轻的COPD患者。COPD急性加重时发生MACE的风险由遗传、行为、代谢、感染和环境风险因素之间的复杂相互作用决定。迄今为止,尚无关于COPD或COPD加重情况下MACE可改变风险因素的预防、筛查和管理的指南,且COPD患者的心血管疾病风险控制不足。深入了解CVD、COPD以及COPD急性加重所共有的可改变风险因素,可能会通过疫苗接种、严格控制传统心血管风险因素和改变生活方式来改善降低COPD患者MACE的策略。本综述总结了关于CVD、COPD以及COPD急性加重所共有的可改变风险因素的病理生理学和流行病学的最新研究,这些因素可能会影响COPD急性加重患者因MACE导致的总体发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e02f/6603127/bd711315e9c7/fcvm-06-00079-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e02f/6603127/bd711315e9c7/fcvm-06-00079-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e02f/6603127/bd711315e9c7/fcvm-06-00079-g0001.jpg

相似文献

1
Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重背景下心血管疾病危险因素对主要心血管事件预防和管理的影响
Front Cardiovasc Med. 2019 Jun 25;6:79. doi: 10.3389/fcvm.2019.00079. eCollection 2019.
2
Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.COPD 稳定合并心血管疾病患者的加重与严重心血管事件相关:一项全国性基于人群的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 1;18:419-429. doi: 10.2147/COPD.S396790. eCollection 2023.
3
Cardiovascular disease in chronic obstructive pulmonary disease: a narrative review.慢性阻塞性肺疾病中的心血管疾病:一篇叙述性综述。
Thorax. 2022 Jun 30. doi: 10.1136/thoraxjnl-2021-218333.
4
Temporal Dynamics of Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease During Stable Disease and Exacerbations: Review of the Mechanisms and Implications.慢性阻塞性肺疾病稳定期和加重期患者心血管风险的时间动态:机制与意义综述。
Int J Chron Obstruct Pulmon Dis. 2024 Oct 10;19:2259-2271. doi: 10.2147/COPD.S466280. eCollection 2024.
5
Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD.COPD 急性加重后发生主要不良心脏事件的风险增加。
Respirology. 2019 Dec;24(12):1183-1190. doi: 10.1111/resp.13620. Epub 2019 Jun 21.
6
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
7
Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis.COPD 加重与急性心血管事件的关联:系统评价和荟萃分析。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221113647. doi: 10.1177/17534666221113647.
8
CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.CHA2DS2-VASc评分可预测慢性阻塞性肺疾病患者的主要不良心血管事件。
Clin Respir J. 2018 Mar;12(3):1038-1045. doi: 10.1111/crj.12624. Epub 2017 Mar 29.
9
The association between recent hospitalized COPD exacerbations and adverse outcomes after percutaneous coronary intervention: a nationwide cohort study.近期住院慢性阻塞性肺疾病加重与经皮冠状动脉介入治疗后不良结局之间的关联:一项全国性队列研究。
Int J Chron Obstruct Pulmon Dis. 2019 Jan 3;14:169-179. doi: 10.2147/COPD.S187345. eCollection 2019.
10
Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.成人非心血管危险因素慢性阻塞性肺疾病加重率的季节性和区域性差异。
Ann Am Thorac Soc. 2018 Nov;15(11):1296-1303. doi: 10.1513/AnnalsATS.201801-070OC.

引用本文的文献

1
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial.针对可改变的高危慢性阻塞性肺疾病患者的改善计划与常规护理的实用性评估:整群随机PREVAIL试验方案
Chronic Obstr Pulm Dis. 2025 May 27;12(3):223-239. doi: 10.15326/jcopdf.2024.0564.
2
Improving COPD Management at Transitions of Care.改善慢性阻塞性肺疾病(COPD)在医疗照护转接过程中的管理。
Fed Pract. 2024 Nov;41(Suppl 6):S29-S34. doi: 10.12788/fp.0533. Epub 2024 Nov 20.
3
Exacerbations Predict Severe Cardiovascular Events in Patients with COPD and Stable Cardiovascular Disease-A Nationwide, Population-Based Cohort Study.

本文引用的文献

1
Epidemiology in diabetes mellitus and cardiovascular disease.糖尿病与心血管疾病的流行病学
Cardiovasc Endocrinol. 2017 Feb 15;6(1):8-16. doi: 10.1097/XCE.0000000000000116. eCollection 2017 Mar.
2
Lipid metabolism in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的脂代谢。
Int J Chron Obstruct Pulmon Dis. 2019 May 13;14:1009-1018. doi: 10.2147/COPD.S196210. eCollection 2019.
3
Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis.基于大数据分析的慢性阻塞性肺疾病恶化相关因素。
COPD 稳定合并心血管疾病患者的加重与严重心血管事件相关:一项全国性基于人群的队列研究。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 1;18:419-429. doi: 10.2147/COPD.S396790. eCollection 2023.
4
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease.慢性阻塞性肺疾病合并心血管疾病的发病机制及药物治疗分析
Front Med (Lausanne). 2022 Nov 4;9:979959. doi: 10.3389/fmed.2022.979959. eCollection 2022.
5
Ebselen abolishes vascular dysfunction in influenza A virus-induced exacerbations of cigarette smoke-induced lung inflammation in mice.依布硒啉可消除甲型流感病毒加重香烟烟雾诱导的小鼠肺部炎症时的血管功能障碍。
Clin Sci (Lond). 2022 Apr 29;136(8):537-555. doi: 10.1042/CS20211090.
6
Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.慢性阻塞性肺疾病急性加重患者合并冠状动脉疾病的临床和经济负担:全国队列研究中的性别差异。
Respir Res. 2022 Feb 12;23(1):28. doi: 10.1186/s12931-022-01945-7.
7
Risk of Coronary Heart Disease in People with Chronic Obstructive Pulmonary Disease: A Meta-Analysis.慢性阻塞性肺疾病患者的冠心病风险:一项荟萃分析。
Int J Chron Obstruct Pulmon Dis. 2021 Oct 27;16:2939-2944. doi: 10.2147/COPD.S331505. eCollection 2021.
8
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care.征服质量标准:用于质量改进合作倡议,以实现 COPD 护理标准卓越。
Int J Chron Obstruct Pulmon Dis. 2021 Aug 12;16:2301-2322. doi: 10.2147/COPD.S313498. eCollection 2021.
Sci Rep. 2019 Apr 30;9(1):6679. doi: 10.1038/s41598-019-43167-w.
4
National and State Estimates of COPD Morbidity and Mortality - United States, 2014-2015.2014 - 2015年美国慢性阻塞性肺疾病发病率和死亡率的全国及各州估计数据
Chronic Obstr Pulm Dis. 2018 Oct 12;5(4):324-333. doi: 10.15326/jcopdf.5.4.2018.0157.
5
Bacterial and Viral Identification Rate in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Korea.韩国慢性阻塞性肺疾病急性加重期的细菌和病毒鉴定率
Yonsei Med J. 2019 Feb;60(2):216-222. doi: 10.3349/ymj.2019.60.2.216.
6
Acute Infection and Myocardial Infarction.急性感染与心肌梗死
N Engl J Med. 2019 Jan 10;380(2):171-176. doi: 10.1056/NEJMra1808137.
7
Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.COPD 中的生物标志物和临床结局:系统评价和荟萃分析。
Thorax. 2019 May;74(5):439-446. doi: 10.1136/thoraxjnl-2018-211855. Epub 2019 Jan 7.
8
Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD.流感疫苗对 COPD 住院患者住院和严重结局风险因素的有效性。
Chest. 2019 Jan;155(1):69-78. doi: 10.1016/j.chest.2018.10.044.
9
Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.中心性肺气肿和冠状动脉钙化:SPIROMICS 队列中的中介分析。
Respir Res. 2018 Dec 18;19(1):257. doi: 10.1186/s12931-018-0946-1.
10
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)的预防性抗生素治疗
Cochrane Database Syst Rev. 2018 Oct 30;10(10):CD009764. doi: 10.1002/14651858.CD009764.pub3.